Janus Henderson Global Life Sciences Fund - T Shares: (MF: JAGLX)
(NA) As of Oct 10, 2025 06:48 PM ET
$73.33 USD
-1.02 (-1.37%)
Zacks MF Rank 2-Buy 2
This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:
| Zacks Rank | Definition |
|---|---|
| 1 | Strong Buy |
| 2 | Buy |
| 3 | Hold |
| 4 | Sell |
| 5 | Strong Sell |
Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
Latest Performance as of Aug 31, 2025
| Total Return %* | Percentile Rank Objective | |
|---|---|---|
| YTD | 2.19 | 34 |
| 3 months | 7.65 | 32 |
| 6 months | -3.31 | 47 |
| 1 Year | -11.43 | 54 |
| 3 Year | 7.94 | 22 |
| 5 Year | 5.94 | 15 |
| 10 Year | 7.30 | 22 |
* Annual for three years and beyond.
Mutual Funds Research & Tools
Search Similar Mutual Funds
Research similar Mutual Funds with higher ranks and performance ratings.
Mutual Funds Comparison View (minimum of 2)
Mutual Funds Screener
Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.
Portfolio Statistics
| %Unrealized Gain YTD | 33.96 |
| % Yield | 0.21 |
| % SEC Yield | |
| Net Assets (Mil $) 8/31/2025 | 1,104.18 |
| %Turnover 8/31/2025 | 28.00 |
Risk
| 3 Year | 5 Year | 10 Year | |
|---|---|---|---|
| Beta | 0.65 | 0.67 | 0.77 |
| Alpha | -5.13 | -4.09 | -3.58 |
| R Squared | 0.42 | 0.50 | 0.55 |
| Std. Dev. | 14.75 | 15.08 | 16.09 |
| Sharpe | 0.28 | 0.27 | 2.00 |
Sector / Country Weightings
| As of 8/31/2025 | % of Portfolio |
|---|---|
| Health | 68.37 |
| Finance | 11.45 |
| Other | 7.77 |
| Services | 4.20 |
| Retail Trade | 3.34 |
| Technology | 3.09 |
| Industrial Cyclical | 1.78 |
Portfolio Holdings
| Top Equity Holdings (As of 3/31/2025) |
% of Portfolio | Value (Mil$) |
|---|---|---|
| ELI LILLY & CO | 9.39 | 442.52 |
| UNITEDHEALTH GROUP INC | 6.87 | 323.58 |
| ASTRAZENECA PLC ADR | 4.01 | 188.84 |
| JOHNSON & JOHNSON | 3.59 | 168.97 |
| BOSTON SCIENTIFIC CORP | 3.13 | 147.35 |
| ABBOTT LABORATORIES | 3.09 | 145.51 |
| SANOFI SA | 3.05 | 143.83 |
| AMGEN INC | 2.89 | 136.17 |
| ABBVIE INC | 2.82 | 133.09 |
Stock Holding % of Net Assets
| As Of | 3/31/2025 |
| Total Issues | 92 |
| Avg. P/E | 26.56 |
| Avg. P/Book | 6.11 |
| Avg. EPS Growth | 13.35 |
| Avg. Market Value (Mil $) | 215,666 |
Allocation
| % of Portfolio | |
| Large Growth | 0.00 |
| Large Value | 16.26 |
| Small Growth | 3.43 |
| Small Value | 0.00 |
| Foreign Stock | 5.67 |
| Emerging Market | 0.00 |
| Precious Metal | 0.76 |
| Intermediate Bond | 16.23 |
| Foreign Bond | 0.00 |
| High Yield Bond | 0.00 |